表紙
市場調查報告書

醫療保健:歐盟的預測與展望 ∼2020年

EU Healthcare Predictions and Outlook, 2020

出版商 Frost & Sullivan 商品編碼 927973
出版日期 內容資訊 英文 56 Pages
商品交期: 最快1-2個工作天內
價格
醫療保健:歐盟的預測與展望 ∼2020年 EU Healthcare Predictions and Outlook, 2020
出版日期: 2020年02月20日內容資訊: 英文 56 Pages
簡介

在全球貿易摩擦形勢上升及全球經濟展望低迷中,預測全球醫療保健市場將在2020年超越2兆美元。在歐洲,BREXIT (脫歐) 有可能對英國,也就是歐洲最大數位健康市場,帶來極大影響。

本報告調查了歐盟的醫療保健市場,並提供了市場概要、部門別市場預測、地區別的獲益預測、主要動向預測、成長機會與受矚目企業、脫歐的影響 & 機會分析等。

執行摘要

  • 市場範圍
  • 地區部門分類
  • 本調查研究的主要項目
  • 歐盟醫療保健產業的主要預測

歐盟醫療保健市場概要

  • 歐盟醫療保健產業預測:部門別
  • 歐盟地區表現矩陣
  • 獲益:地區別

歐盟醫療保健產業預測

  • 預測#1:到2020年為止,孤兒藥的R&D研發會超過非孤兒藥,佔研發總額的55%
  • 預測#2:歐洲的生物製造能力最多會擴大15%,在2020年之前達成35%的市佔率
  • 預測#3:2020年,歐洲會出現人工智慧的反曲點
  • 預測#4:醫院的成本減輕,在2020年為止會增加25%∼35%,手術室的15%∼20%會被整合
  • 預測#5:針對感染症的POCT市場會在2020年突破10億美元
  • 預測#6:歐洲會在2020年領導全球VF市場,佔市佔率的40%
  • 預測#7:由於精密醫療處置的需求,RASD會在2020年之前達成4億3,000萬美元,併發症比率減輕10%∼15%
  • 預測#8:新一代影像設備會設定成一年能減輕10%∼12%的運用成本
  • 預測#9:由於醫療級的遠距患者監測,顯示15%的成長
  • 預測#10:最多20個新企業與客戶的夥伴關係重新定義了新的商業模式

歐盟醫療保健產業中的成長機會:部門別

  • 主要的醫藥品、生物科技成長機會
  • 主要醫療技術的成長機會
  • 主要醫療用影像設備的成長機會
  • 主要體外診斷藥的成長機會
  • 主要醫療保健IT的成長機會
  • 受矚目的公司

歐盟醫療保健產業獲益預測:部門別

  • 醫療保健IT
  • 醫療技術
  • 醫療用影像設備
  • 醫藥品 & 生物科技
  • 體外診斷用醫藥品

Brexit (脫歐) :影響 & 機會分析

  • 支援持續保健的英國與歐洲的相互依賴關係
  • 評估醫療制度的主要指標
  • 橫跨英國醫療保健部門的潛在混亂

結論

附錄

關於Frost & Sullivan

目錄
Product Code: MEE1-50

Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national healthcare policies and regulatory reforms that must re-invigorate future strategies. Social Determinants of Health (SDOH) will emerge as a big theme across progressive health systems as they seek to proactively engage patients and improve health outcomes that would help healthcare organizations meet quality standards.

This decade will bring significant changes and disruptions when it comes to digital-service-enabled health. Health and care delivery, as well as prevention in the 2020s, will become more consumer-centric, with AI-powered tools and virtual interactions between patients and care providers becoming the new normal in many situations. Data-driven interoperability and personalized diagnostics will accelerate the delivery of predictive-analysis-driven precision care. This will pave the way for better and efficient decision making for the patient and the provider and further drive partnerships between big tech companies that design care delivery models and healthcare organizations.

This follows the new vision for healthcare for 2020 and beyond, focusing not only on access, quality, and affordability but also on predictive, preventive, and outcome-based care models that promote social and financial inclusion. In 2020, consumer-driven models of healthcare will gain more market traction, as they stand to better bridge the gap of what consumers want and what healthcare can deliver.

Central and Eastern Europe is highly fragmented and is emerging as quite an attraction to healthcare investors. Screening services are facilitating better diagnosis of chronic conditions. The rise in disposable income and in healthcare spending is because of the presence of a rapidly aging population and their demand for better healthcare. Economic factors are also at play, with rising wages and disposable incomes freeing up personal money for healthcare-related spending. With the recent rise in minimum wages in Hungary and other recent reforms in various parts of Central and Eastern Europe, the economy in CEE and a parallel drop in unemployment rates are ideal for market participants.

Table of Contents

Executive Summary

  • Market Scope
  • Geographic Segmentation
  • Key Questions This Study Will Answer
  • Top Predictions for the EU Healthcare Industry, 2020

Overview of the 2020 EU Healthcare Market

  • EU Healthcare Industry Forecast by Segment
  • EU Regional Performance Matrix
  • Revenue by Region

2020 Predictions for EU Healthcare Industry

  • Prediction#1: By 2020, Orphan Drug R&D Pipeline will Surpass Non-orphan Drug to Account for 55% of the Total Pipeline Value
  • Prediction#2: Europe will Expand Biomanufacturing Capacity by ~15% to Reach a Market Share of 35% by 2020
  • Prediction#3: 2020 will be an Inflexion Point for Artificial Intelligence in Europe
  • Prediction#4: Hospital Cost Saving is Set to Increase by 25%-35% by 2020 as 15%-20% of ORs become Integrated
  • Prediction#5: POCT Market for Infectious Diseases will Breach the One-billion-dollar Mark in 2020
  • Prediction#6: Europe will Lead the Global IVF Market in 2020 and Account for 40% of Market Share
  • Prediction#7: The Demand for Precision Care Procedures will Fuel RASD to Reach $430 million by 2020 and Cut Complication Rates by 10%-15%
  • Prediction#8: Next-gen Imaging Equipment is set to Yield Annual Operational Savings of 10%-12%
  • Prediction#9: Medical-grade remote patient monitoring will witness a 15% growth
  • Prediction#10: Up to 20 New Enterprise-customer Partnerships will Redefine New Business Models

Growth Opportunities for the EU Healthcare Industry by Sector

  • Top Pharmaceuticals and Biotechnology Growth Opportunities
  • Top Medical Technologies Growth Opportunities
  • Top Medical Imaging Equipment Growth Opportunities
  • Top In-Vitro Diagnostics Growth Opportunities
  • Top Healthcare IT Growth Opportunities
  • Companies to Watch Out For
  • Companies to Watch Out for (continued)

2020 Revenue Forecast for EU Healthcare Industry by Sector

  • Healthcare IT
  • Medical Technologies
  • Medical Imaging Equipment
  • Pharmaceutical & Biotechnology
  • In-Vitro Diagnostics

Brexit: Impact & Opportunity Analysis

  • UK and Europe's Interdependencies that Support the Care Continuum
  • Select Indicators for Health System Assessment
  • Potential Disruption Across the UK Healthcare Sector

The Last Word

  • Critical Success Factors
  • Legal Disclaimer

Appendix

  • List of Exhibits
  • List of Exhibits (continued)

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360º Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy